Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Gross Profit: 2017-2019

Historic Gross Profit for Neurocrine Biosciences (NBIX) over the last 3 years, with Dec 2019 value amounting to $780.7 million.

  • Neurocrine Biosciences' Gross Profit rose 14.07% to $291.8 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.1 billion, marking a year-over-year increase of 3.36%. This contributed to the annual value of $780.7 million for FY2019, which is 74.92% up from last year.
  • Per Neurocrine Biosciences' latest filing, its Gross Profit stood at $780.7 million for FY2019, which was up 74.92% from $446.3 million recorded in FY2018.
  • In the past 5 years, Neurocrine Biosciences' Gross Profit ranged from a high of $780.7 million in FY2019 and a low of $13.7 million during FY2017.
  • For the 3-year period, Neurocrine Biosciences' Gross Profit averaged around $413.6 million, with its median value being $446.3 million (2018).
  • Data for Neurocrine Biosciences' Gross Profit shows a peak YoY surged of 3,146.84% (in 2018) over the last 5 years.
  • Over the past 3 years, Neurocrine Biosciences' Gross Profit (Yearly) stood at $13.7 million in 2017, then surged by 3,146.84% to $446.3 million in 2018, then spiked by 74.92% to $780.7 million in 2019.